Establishment of a Mitochondrial Metabolism-Related Diagnostic Model in Schizophrenia Based on LASSO Algorithm

키워드

참고문헌 (47)

1. Mueser KT, "Schizophrenia", Lancet, 363, pp.2063~2072 (2004)
2. Cheng W, "Genetic association between schizophrenia and cortical brain surface area and thickness", JAMA Psychiatry, 78, pp.1020~1030 (2021)
3. Ross CA, "Neurobiol ogy of schizophrenia", Neuron, 52, pp.139~153 (2006)
4. Mandal PK, "Schizo phrenia, bipolar and major depressive disorders : overview of clinical features, neurotransmitter alterations, pharmacological interventions, and impact of oxidative stress in the disease process", ACS Chem Neu rosci, 13, pp.2784~2802 (2022)
5. Stilo SA, "Non-genetic factors in schizophrenia", Curr Psychiatry Rep, 21, pp.100~ (2019)
6. Ahmed AO, "Schizophrenia heterogeneity revisited : clinical, cognitive, and psycho social correlates of statistically-derived negative symptoms subgroups", J Psychiatr Res, 97, pp.8~15 (2018)
7. Chai C, "Dissociation be tween neuroanatomical and symptomatic subtypes in schizophrenia", Eur Psychiatry, 66, pp.e78~ (2023)
8. Fervaha G, "Neurocognitive impairment in the deficit subtype of schizophrenia", Eur Arch Psychiatry Clin Neurosci, 266, pp.397~407 (2016)
9. Hasan A, "Early detection and treatment of schizophrenia", MMW Fortschr Med, 152, pp.53~55 (2010)
10. Bighelli I, "Psychosocial and psychological interven tions for relapse prevention in schizophrenia : a systematic review and network meta-analysis", Lancet Psychiatry, 8, pp.969~980 (2021)
11. Sabaie H, "Downregulation of miR-185 is a common pathogenic event in 22q11. 2 deletion syndrome-related and idiopathic schizophrenia", Metab Brain Dis, 37, pp.1175~1184 (2022)
12. Vigani G, "Signals from chlo roplasts and mitochondria for iron homeostasis regulation", Trends Plant Sci, 18, pp.305~311 (2013)
13. Choudhury M, "Wide spread RNA hypoediting in schizophrenia and its relevance to mito chondrial function", Sci Adv, 9, pp.eade9997~ (2023)
14. Lv T, "Mitochondrial general con trol of amino acid synthesis 5 like 1 promotes nonalcoholic steatohep atitis development through ferroptosis-induced formation of neutro phil extracellular traps", Clin Transl Med, 13, pp.e1325~ (2023)
15. Richter-Dennerlein R, "Integrating mitochon drial translation into the cellular context", Nat Rev Mol Cell Biol, 16, pp.586~592 (2015)
16. Kim Y, "Mitochondria, metabolism, and redox mechanisms in psychiatric disorders", Antioxid Redox Signal, 31, pp.275~317 (2019)
17. Fizíková I, "Mitochondrial dysfunction, altered mitochondrial oxygen, and energy metabolism associated with the pathogenesis of schizophrenia", Int J Mol Sci, 24, pp.7991~ (2023)
18. Ben-Shachar D, "Mitochondrial multifaceted dysfunction in schizo phrenia; complex I as a possible pathological target", Schizophr Res, 187, pp.3~10 (2017)
19. Whitehurst T, "The role of mitochondria in the pathophysiol ogy of schizophrenia : a critical review of the evidence focusing on mi tochondrial complex one", Neurosci Biobehav Rev, 132, pp.449~464 (2022)
20. Konradi C, "Role of mitochondria and energy metabolism in schizophrenia and psychotic disorders", Schizophr Res, 187, pp.1~2 (2017)
21. Ni P, "Mitochondrial dysfunction in psychiatric disor ders", Schizophr Res (2022)[DOI]
22. Meng C, "Establishment of a prognostic model for ovari an cancer based on mitochondrial metabolism-related genes", Front Oncol, 13, pp.1144430~ (2023)
23. Wu T, "clusterProfiler 4. 0 : a universal enrichment tool for interpreting omics data", Innovation(Camb), 2, pp.100141~ (2021)
24. Guo A, "Bioinformatic identifica tion of hub genes Myd88 and Ccl3 and TWS-119 as a potential agent for the treatment of massive cerebral infarction", Front Neurosci, 17, pp.1171112~ (2023)
25. Park C, "Molecular links between mitochondrial dysfunctions and schizophrenia", Mol Cells, 33, pp.105~110 (2012)
26. Roberts RC, "Mitochondrial dysfunction in schizophrenia : with a focus on postmortem studies", Mitochondrion, 56, pp.91~101 (2021)
27. Gonçalves VF, "Mitochondrial dysfunction in schizophrenia : an evolutionary perspective", Hum Genet, 134, pp.13~21 (2015)
28. Beeraka NM, "Recent reports on redox stress-induced mitochondrial DNA variations, neuroglial interactions, and NMDA receptor system in pathophysiology of schizophrenia", Mol Neurobiol, 59, pp.2472~2496 (2022)
29. Fišar Z, "Biological hypotheses, risk factors, and biomarkers of schizo phrenia", Prog Neuropsychopharmacol Biol Psychiatry, 120, pp.110626~ (2023)
30. Duarte JMN, "Magnetic resonance spectroscopy in schizophre nia : evidence for glutamatergic dysfunction and impaired energy me tabolism", Neurochem Res, 44, pp.102~116 (2019)
31. Wang D, "Metabolic profiling identifies phospholipids as potential serum biomarkers for schizophrenia", Psychiatry Res, 272, pp.18~29 (2019)
32. Hatano T, "Plasma alanine levels increase in patients with schizophrenia as their clinical symptoms improve-results from the Juntendo University Schizophrenia Projects(JUSP)", Psychiatry Res, 177, pp.27~31 (2010)
33. Moghaddam B, "From revolution to evolution : the glutamate hypothesis of schizophrenia and its implication for treatment", Neuropsychopharmacology, 37, pp.4~15 (2012)
34. Merritt K, "Nature of glutamate alterations in schizophrenia : a meta-analysis of proton mag netic resonance spectroscopy studies", JAMA Psychiatry, 73, pp.665674~ (2016)
35. Schiano C, "Mediator complex in neu rological disease", Life Sci, 329, pp.121986~ (2023)
36. Becerril S, "Transcriptional analysis of brown adipose tissue in leptin deficient mice lacking inducible nitric oxide synthase : evidence of the role of Med1 in energy balance", Physiol Genomics, 44, pp.678~688 (2012)
37. Li K, "miR-146a improves hepatic lipid and glucose metabolism by targeting MED1", Int J Mol Med, 45, pp.543~555 (2020)
38. Okamoto H, "Ang ptl4 does not control hyperglucagonemia or α-cell hyperplasia follow ing glucagon receptor inhibition", Proc Natl Acad Sci U S A, 114, pp.2747~2752 (2017)
39. Aryal B, "ANGPTL4 in met abolic and cardiovascular disease", Trends Mol Med, 25, pp.723~734 (2019)
40. Dewey FE, "Inactivating variants in ANGPTL4 and risk of coronary artery disease", N Engl J Med, 374, pp.1123~1133 (2016)
41. Zheng X, "ANGPTL4-medi ated promotion of glycolysis facilitates the colonization of Fusobacteri um nucleatum in colorectal cancer", Cancer Res, 81, pp.6157~6170 (2021)
42. Wang Y, "Overex pression of angiopoietin-like protein 4 alters mitochondria activities and modulates methionine metabolic cycle in the liver tissues of db", db diabetic mice, 2007, pp.21, 972~986
43. Jiang N, "Fatty acid oxida tion fuels glioblastoma radioresistance with CD47-mediated immune evasion", Nat Commun, 13, pp.1511~ (2022)
44. Aires V, "Resveratrol-induced changes in MicroRNA expression in primary hu man fibroblasts harboring carnitine-palmitoyl transferase-2 gene muta tion, leading to fatty acid oxidation deficiency", Molecules, 23, pp.7~ (2017)
45. Virmani A, "The carnitine palmitoyl transferase(CPT)system and possi ble relevance for neuropsychiatric and neurological conditions", Mol Neurobiol, 52, pp.826~836 (2015)
46. Asraf K, "Synergistic, long-term effects of glutamate dehydrogenase 1 deficiency and mild stress on cognitive function and mPFC gene and miRNA expression", Transl Psychiatry, 13, pp.248~ (2023)
47. Yadav R, "Dele tion of glutamate delta-1 receptor in mouse leads to aberrant emotional and social behaviors", PLoS One, 7, pp.e32969~ (2012)

관련 논문AI추천